• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1.

作者信息

Bayle A, Khettab M, Lucibello F, Chamseddine A N, Goldschmidt V, Perret A, Ropert S, Scotté F, Loulergue P, Mir O

机构信息

Department of Drug Development/DITEP, Gustave Roussy Cancer Institute, Villejuif, France.

Department of Cancer Medicine, Gustave Roussy Cancer Institute, Chevilly-Larue, France.

出版信息

Ann Oncol. 2020 Jul;31(7):959-961. doi: 10.1016/j.annonc.2020.03.290. Epub 2020 Mar 26.

DOI:10.1016/j.annonc.2020.03.290
PMID:32224150
Abstract
摘要

相似文献

1
Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1.接受靶向PD-1或PD-L1的检查点抑制剂治疗的癌症患者中流感疫苗接种的免疫原性和安全性。
Ann Oncol. 2020 Jul;31(7):959-961. doi: 10.1016/j.annonc.2020.03.290. Epub 2020 Mar 26.
2
[Influenza vaccination in advanced cancer patients undergoing immunotherapy with anti-PD-1/PD-L1 immune checkpoint inhibitors: what data do we have for the clinical recommendation?].[接受抗PD-1/PD-L1免疫检查点抑制剂免疫治疗的晚期癌症患者的流感疫苗接种：我们有哪些数据可用于临床推荐？]
Recenti Prog Med. 2018 Nov;109(11):540-546. doi: 10.1701/3031.30291.
3
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action.程序性细胞死亡蛋白-1/程序性细胞死亡配体-1 检查点抑制剂：作用机制的差异。
Immunotherapy. 2019 Apr;11(5):429-441. doi: 10.2217/imt-2018-0110. Epub 2019 Jan 30.
4
Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy.小分子 PD-1/PD-L1 免疫检查点抑制剂的开发作为肿瘤免疫治疗的新治疗策略。
J Drug Target. 2019 Mar;27(3):244-256. doi: 10.1080/1061186X.2018.1440400. Epub 2018 Feb 20.
5
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events.另一角度看待癌症患者 BMI 与程序性死亡蛋白-1（PD-1）/程序性死亡配体 1（PD-L1）检查点抑制剂临床获益的相关性：免疫相关不良事件的多中心分析。
Eur J Cancer. 2020 Mar;128:17-26. doi: 10.1016/j.ejca.2019.12.031. Epub 2020 Mar 5.
6
[Predictive diagnostics of the programmed cell death receptor 1 (PD-1) - programmed cell death ligand 1 (PD-L1) inhibitory therapies].程序性细胞死亡受体1（PD-1）-程序性细胞死亡配体1（PD-L1）抑制疗法的预测性诊断
Magy Onkol. 2019 Sep 18;63(3):183-191. Epub 2019 Aug 30.
7
[Progress in Clinical Researches of PD-1/PD-L1 Checkpoint Inhibitor for Non-small Cell Lung Cancer].[PD-1/PD-L1检查点抑制剂治疗非小细胞肺癌的临床研究进展]
Zhongguo Fei Ai Za Zhi. 2019 Jul 20;22(7):440-448. doi: 10.3779/j.issn.1009-3419.2019.07.06.
8
Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy.靶向细胞程序性死亡受体 1（PD-1）及其配体（PD-L1）：癌症主动免疫治疗的新纪元。
Pharmacol Ther. 2019 Feb;194:84-106. doi: 10.1016/j.pharmthera.2018.09.008. Epub 2018 Sep 28.
9
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.下一代免疫检查点抑制剂：黑色素瘤中的PD-1/PD-L1阻断
Clin Ther. 2015 Apr 1;37(4):764-82. doi: 10.1016/j.clinthera.2015.02.018. Epub 2015 Mar 29.
10
[Role of PD-1/PD-L1 in microenvironment of breast cancer].[PD-1/PD-L1在乳腺癌微环境中的作用]
Zhonghua Zhong Liu Za Zhi. 2019 Jun 23;41(6):401-405. doi: 10.3760/cma.j.issn.0253-3766.2019.06.001.

引用本文的文献

1
A phase II study of nivolumab, ipilimumab, and radiation in combination with influenza vaccine in patients with pancreatic cancer (INFLUENCE).纳武单抗、伊匹单抗及放疗联合流感疫苗用于胰腺癌患者的II期研究（INFLUENCE）
Immunooncol Technol. 2025 Apr 20;26:101054. doi: 10.1016/j.iotech.2025.101054. eCollection 2025 Jun.
2
Impact of systemic anticancer therapy timing on cancer vaccine immunogenicity: a review.全身抗癌治疗时机对癌症疫苗免疫原性的影响：综述
Ther Adv Med Oncol. 2025 Feb 27;17:17588359251316988. doi: 10.1177/17588359251316988. eCollection 2025.
3
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience.
意大利新冠疫情期间针对正在接受积极治疗的癌症患者及其家属的医院流感和肺炎球菌疫苗接种：单中心经验
Vaccines (Basel). 2024 Jun 8;12(6):642. doi: 10.3390/vaccines12060642.
4
Improving Influenza Vaccination Coverage in Patients with Cancer: A Position Paper from a Multidisciplinary Expert Group.提高癌症患者的流感疫苗接种率：多学科专家组立场文件
Vaccines (Basel). 2024 Apr 16;12(4):420. doi: 10.3390/vaccines12040420.
5
Effect of medical staff training on vaccination coverage in outpatients with cancer: An interventional multicenter before-and-after study.医务人员培训对癌症门诊患者疫苗接种覆盖率的影响：一项多中心干预前后研究。
Vaccine X. 2023 Jan 8;13:100261. doi: 10.1016/j.jvacx.2023.100261. eCollection 2023 Apr.
6
Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis.接受免疫检查点抑制剂治疗的患者接种流感疫苗的安全性和有效性。系统评价与荟萃分析
Vaccines (Basel). 2022 Jul 27;10(8):1195. doi: 10.3390/vaccines10081195.
7
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.PD-1 靶向免疫疗法改变了季节性流感疫苗的滤泡辅助性 T 细胞和体液免疫应答。
Nat Immunol. 2022 Aug;23(8):1183-1192. doi: 10.1038/s41590-022-01274-3. Epub 2022 Jul 28.
8
Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in Japan.在接受免疫检查点抑制剂治疗的肺癌患者中，严重急性呼吸综合征冠状病毒 2 信使核糖核酸疫苗的安全性和免疫原性：日本多中心观察研究。
J Thorac Oncol. 2022 Aug;17(8):1002-1013. doi: 10.1016/j.jtho.2022.05.015. Epub 2022 Jun 22.
9
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.在2019冠状病毒病大流行期间管理血液系统癌症患者：ESMO-EHA跨学科专家共识
ESMO Open. 2022 Apr;7(2):100403. doi: 10.1016/j.esmoop.2022.100403. Epub 2022 Jan 28.
10
SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021).SEOM 临床指南：癌症患者感染性疾病的预防（2021 年）。
Clin Transl Oncol. 2022 Apr;24(4):724-732. doi: 10.1007/s12094-022-02800-3. Epub 2022 Mar 1.